Decentralized Clinical Trials: The New Standard in Clinical Research It takes 12 years on average for a new drug to gain market approval from the preclinical stage and costs varying from $1-2.8 billion. Traditional clinical trials have been hampered by systemic challenges, from patient recruitment and retention to the geographic and
Optimizing Clinical Trial Budgeting: How AI-Powered CTOps by Mushroom Solutions Eliminates Hidden Costs and Accelerates Timelines Clinical research sites often encounter numerous financial challenges due to hidden costs that aren’t covered by standard study budgets. These additional expenses, ranging from administrative overheads to unforeseen regulatory requirements, can put a strain
How CMC Automation with AI Is Transforming Regulatory Reporting According to McKinsey, CMC “has a rare opportunity to reimagine its role and find innovative ways to improve and accelerate drug development.” CMC (chemistry, manufacturing, and controls) also known as Pharma Technical Development, develops processes and methods for producing safe and
Advanced Coverage Analysis with CTOps: Addressing Key Challenges for Sites and CROs In the clinical trials industry, ensuring that coverage analysis meets audit standards is critical. Coverage analysis, which involves determining whether the procedures performed during a clinical trial are covered by the sponsor’s insurance, plays a key role in
Is your regulatory team ready for the next FDA Deficiency Letters? FDA’s Center for Devices and Radiological Health (CDRH) reports over 55% of 510(k) submissions receive at least one Additional Information or Deficiency Letter—often due to missing data, unclear testing, or labeling issues. Across the product lifecycle, from preclinical to
The Gitnux 2025 Compliance Statistics report found that 59% of compliance breaches are caused by human error, and 40% of organizations experience difficulty in tracking compliance documentation after audits. With increasing complexity, growing cyber risks, and the high cost of manual processes, businesses are under pressure to enhance compliance frameworks.
In 2025, as pharmaceutical sponsors push for faster, more efficient, and patient-centric drug development, CROs must move beyond traditional service delivery models. Embracing digital-first strategies is essential for staying competitive, compliant, and connected to the needs of patients and regulators alike. This article explores the top five digital transformation priorities
The transformation of clinical trials into efficient, compliant, and patient-focused ecosystems is no longer a future ambition — it’s happening now, decisively driven by automation. In today’s fast-evolving healthcare landscape, automation isn’t optional. It’s a strategic necessity that eliminates hidden costs, reduces manual inefficiencies, and accelerates Clinical Trial Time from
Smarter Clinical Trials with AI in SDTM Automation 50% of biopharmaceutical professionals identified either the variety of data types (26%) or lack of standardization (24%) as their primary challenges when dealing with external data sources in clinical trials. In clinical research, data consistency is the key to seamless operations and
